Drug discovery banner

Drug Discovery Drug Discovery

Breadcrumb

Drug Discovery Overview

Structure-based drug design, synthesis and analytical support to discover promising new therapeutics

The Drug Discovery Platform provides structure-based drug design and synthetic support to researchers. With our drug discovery expertise and state-of-the-art analytical instrument facilities, we identify and validate promising new biological and chemical entities (including biomarkers) for life-threatening diseases. The new therapeutic entities then undergo a series of optimization processes to deliver drug candidates (CDs) which may ultimately lead to clinical trials in the Centre for Innovative Medicine (CIM). The Drug Discovery Platform also provides access and training to users from both academia and industry on a broad range of cutting-edge technologies.

Platform News and Events

News and Events

Asset Publisher

Brain cancer: An intelligent molecule to fool and kill glioblastoma cells

An RI-MUHC research team is working to extend lives of patients with an incurable cancer

Behind the Scenes at the RI-MUHC Technology Platforms

Public tours followed the journey of a cancer research sample at the Glen site

Platform Expo (October 3, 2019)

The RI-MUHC Trainee Committee and CTB Technology Platforms invite you to attend the Platform Expo on October 3, 2019.

Drug Discovery Leader

Director
Dr. Bertrand Jean-Claude


 


Manager
Sanjoy Kumar Das, PhD

Staff
Anne-Laure Larroque, PhD
Andrée Gravel, PhD
Nidia Lauzon, PhD

drugdiscovery.rimuhc@mcgill.ca
514-934-1934 ext. 76350
Office: E01.3625